These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The value of chemoradiotherapy in the management of locally advanced pancreatic adenocarcinoma: systematic review]. Azria D; Seblain-El-Guerche C; Girard N; Hennequin C; Huguet F Bull Cancer; 2008 Nov; 95(11):1116-30. PubMed ID: 19036684 [TBL] [Abstract][Full Text] [Related]
3. [Locally advanced pancreatic adenocarcinoma. Chemoradiotherapy, reevaluation and secondary resection]. Delpero JR; Turrini O Cancer Radiother; 2006 Nov; 10(6-7):462-70. PubMed ID: 16987678 [TBL] [Abstract][Full Text] [Related]
4. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection? Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073 [TBL] [Abstract][Full Text] [Related]
5. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma. Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038 [TBL] [Abstract][Full Text] [Related]
6. The role of radiotherapy in multimodal treatment of pancreatic carcinoma. Brunner TB; Scott-Brown M Radiat Oncol; 2010 Jul; 5():64. PubMed ID: 20615227 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival. Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382 [TBL] [Abstract][Full Text] [Related]
9. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival. Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642 [TBL] [Abstract][Full Text] [Related]
10. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. White R; Lee C; Anscher M; Gottfried M; Wolff R; Keogan M; Pappas T; Hurwitz H; Tyler D Ann Surg Oncol; 1999; 6(1):38-45. PubMed ID: 10030414 [TBL] [Abstract][Full Text] [Related]
11. Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease. Soloff EV; Zaheer A; Meier J; Zins M; Tamm EP Abdom Radiol (NY); 2018 Feb; 43(2):301-313. PubMed ID: 29198002 [TBL] [Abstract][Full Text] [Related]
12. Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma. Hu Q; Wang D; Chen Y; Li X; Cao P; Cao D Radiat Oncol; 2019 Jul; 14(1):120. PubMed ID: 31291998 [TBL] [Abstract][Full Text] [Related]